Chapter 2 Homo- and Hetero-Oligomerization of Chemokines

Methods in Enzymology

Volumn 461, Issue B, 2009, Pages 31-50

  Jansma, Ariane ^a   Handel, Tracy M ^a   Hamel, Damon J ^a  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; OLIGOMER;

DIFFUSION; FLUORESCENCE POLARIZATION; HETERONUCLEAR SINGLE QUANTUM COHERENCE; HUMAN; ION CYCLOTRON RESONANCE MASS SPECTROMETRY; LIGHT SCATTERING; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; NUCLEAR OVERHAUSER EFFECT; OLIGOMERIZATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN STRUCTURE; QUANTITATIVE ANALYSIS; REVIEW; SEDIMENTATION; ULTRACENTRIFUGATION;

CHEMOKINES; CHROMATOGRAPHY, GEL; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; PROTEIN MULTIMERIZATION; PROTEIN STRUCTURE, SECONDARY; SCATTERING, RADIATION; ULTRACENTRIFUGATION;

EID: 65749106394     PISSN: 00766879     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0076-6879(09)05402-0     Document Type: Review

References (53)

1. Allen S.J., Crown S.E., and Handel T.M. Chemokine: Receptor structure, interactions, and antagonism. Annu. Rev. Immunol. 25 (2007) 787-820
2. Altieri A.S. Association of biomolecular systems via pulsed field gradient NMR self-diffusion measurements. J. Am. Chem. Soc. 7 (1995) 740-743
3. Baggiolini M. Chemokines and leukocyte traffic. Nature 392 (1998) 565-568
4. Baggiolini M., Dewald B., and Moser B. Human chemokines: An update. Annu. Rev. Immunol. 15 (1997) 675-705
5. Balbo A., Brown P.H., Braswell E.H., and Schuck P. Measuring protein-protein interactions by equilibrium sedimentation. Curr. Protoc. Immunol. 18 (2007) 188
6. Baldwin E.T., Weber I.T., St. Charles R., Xuan J.C., Appella E., Yamada M., Matsushima K., Edwards B.F., Clore G.M., and Gronenborn A.M. Crystal structure of interleukin 8: Symbiosis of NMR and crystallography. Proc. Natl. Acad. Sci. USA 88 (1991) 502-506
7. Barinka C., Prahl A., and Lubkowski J. Structure of human monocyte chemoattractant protein 4 (MCP-4/CCL13). Acta Crystallogr. D Biol. Crystallogr. 64 (2008) 273-278
8. Baryshnikova O.K., and Sykes B.D. Backbone dynamics of SDF-1alpha determined by NMR: Interpretation in the presence of monomer-dimer equilibrium. Protein Sci. 15 (2006) 2568-2578
9. Blain K.Y., Kwiatkowski W., Zhao Q., La Fleur D., Naik C., Chun T.-W., Tsareva T., Kanakaraj P., Laird M.W., Shah R., George L., Sanyal I., et al. Structural and functional characterization of CC chemokine CCL14. Biochemistry 46 (2007) 10008-10015
10. Breeze A.L. Isotope-filtered NMR methods for the study of biomolecular structure and interactions. Progr. Nucl. Magn. Reson. Spectrosc. 36 (2000) 323-372
11. Campanella G.S., Grimm J., Manice L.A., Colvin R.A., Medoff B.D., Wojtkiewicz G.R., Weissleder R., and Luster A.D. Oligomerization of CXCL10 is necessary for endothelial cell presentation and in vivo activity. J. Immunol. 177 (2006) 6991-6998
12. Clore G.M., Appella E., Yamada M., Matsushima K., and Gronenborn A.M. Three-dimensional structure of interleukin 8 in solution. Biochemistry 29 (1990) 1689-1696
13. Crown S.E., Yu Y., Sweeney M.D., Leary J.A., and Handel T.M. Heterodimerization of CCR2 chemokines and regulation by glycosaminoglycan binding. J. Biol. Chem. 281 (2006) 25438-25446
14. Czaplewski L.G., McKeating J., Craven C.J., Higgins L.D., Appay V., Brown A., Dudgeon T., Howard L.A., Meyers T., Owen J., Palan S.R., Tan P., et al. Identification of amino acid residues critical for aggregation of human CC chemokines macrophage inflammatory protein (MIP)-1alpha, MIP-1beta, and RANTES. Characterization of active disaggregated chemokine variants. J. Biol. Chem. 274 (1999) 16077-16084
15. Dudek A.Z., Nesmelova I., Mayo K., Verfaillie C.M., Pitchford S., and Slungaard A. Platelet factor 4 promotes adhesion of hematopoietic progenitor cells and binds IL-8: Novel mechanisms for modulation of hematopoiesis. Blood 101 (2003) 4687-4694
16. Ellyard J.I., Simson L., Bezos A., Johnston K., Freeman C., and Parish C.R. Eotaxin selectively binds heparin. An interaction that protects eotaxin from proteolysis and potentiates chemotactic activity in vivo. J. Biol. Chem. 282 (2007) 15238-15247
17. Fermas S., Gonnet F., Sutton A., Charnaux N., Mulloy B., Du Y., Baleux F., and Daniel R. Sulfated oligosaccharides (heparin and fucoidan) binding and dimerization of stromal cell-derived factor-1 (SDF-1/CXCL 12) are coupled as evidenced by affinity CE-MS analysis. Glycobiology 18 (2008) 1054-1064
18. Fernandez E.J., and Lolis E. Structure, function, and inhibition of chemokines. Annu. Rev. Pharmacol. Toxicol. 42 (2002) 469-499
19. Fox J.M., Najarro P., Smith G.L., Struyf S., Proost P., and Pease J.E. Structure/function relationships of CCR8 agonists and antagonists. Amino-terminal extension of CCL1 by a single amino acid generates a partial agonist. J. Biol. Chem. 281 (2006) 36652-36661
20. Handel T.M., and Domaille P.J. Heteronuclear (1H, 13C, 15N) NMR assignments and solution structure of the monocyte chemoattractant protein-1 (MCP-1) dimer. Biochemistry 35 (1996) 6569-6584
21. Handel T.M., Johnson Z., Crown S.E., Lau E.K., and Proudfoot A.E. Regulation of protein function by glycosaminoglycansas exemplified by chemokines. Annu. Rev. Biochem. 74 (2005) 385-410
22. Handel T.M., Johnson Z., Rodrigues D.H., dos Santos A.C., Cirillo R., Muzio V., Riva S., Mack M., Déruaz M., Borlat F., Vitte P.-A., Wells T.N.C., et al. An engineered monomer of CCL2 has anti-inflammatory properties emphasizing the importance of oligomerization for chemokine activity in vivo Inhibition of monocyte chemoattractant protein-1 ameliorates rat adjuvant-induced arthritis. J. Leukoc. Biol. 84 (2008) 1101-1108
23. Holmes W.D., Consler T.G., Dallas W.S., Rocque W.J., and Willard D.H. Solution studies of recombinant human stromal-cell-derived factor-1. Protein Expr. Purif. 21 (2001) 367-377
24. Homey B., Alenius H., Müller A., Soto H., Bowman E.P., Yuan W., McEvoy L., Lauerma A.I., Assmann T., Bünemann E., Lehto M., Wolff H., et al. CCL27-CCR10 interactions regulate T cell-mediated skin inflammation. Nat. Med. 8 (2002) 157-165
25. Hoogewerf A.J., Kuschert G.S., Proudfoot A.E., Borlat F., Clark-Lewis I., Power C.A., and Wells T.N. Glycosaminoglycans mediate cell surface oligomerization of chemokines. Biochemistry 36 (1997) 13570-13578
26. Imberty A., Lortat-Jacob H., and Perez S. Structural view of glycosaminoglycan-protein interactions. Carbohydr. Res. 342 (2007) 430-439
27. Ishima R., and Torchia D.A. Protein dynamics from NMR. Nat. Struct. Biol. 7 (2000) 740-743
28. Jin H., Hayes G.L., Darbha N.S., Meyer E., and LiWang P.J. Investigation of CC and CXC chemokine quaternary state mutants. Biochem. Biophys. Res. Commun. 338 (2005) 987-999
29. Jin H., Shen X., Baggett B.R., Kong X., and LiWang P.J. The human CC chemokine MIP-1beta dimer is not competent to bind to the CCR5 receptor. J. Biol. Chem. 282 (2007) 27976-27983
30. Johnson Z., Kosco-Vilbois M.H., Herren S., Cirillo R., Muzio V., Zaratin P., Carbonatto M., Mack M., Smailbegovic A., Rose M., Lever R., Page C., et al. Interference with heparin binding and oligomerization creates a novel anti-inflammatory strategy targeting the chemokine system. J. Immunol. 173 (2004) 5776-5785
31. Johnson Z., Proudfoot A.E., and Handel T.M. Interaction of chemokines and glycosaminoglycans: A new twist in the regulation of chemokine function with opportunities for therapeutic intervention. Cytokine Growth Factor Rev. 16 (2005) 625-636
32. Kuschert G.S., Coulin F., Power C.A., Proudfoot A.E., Hubbard R.E., Hoogewerf A.J., and Wells T.N. Glycosaminoglycans interact selectively with chemokines and modulate receptor binding and cellular responses. Biochemistry 38 (1999) 12959-12968
33. Lau E.K., Paavola C.D., Johnson Z., Gaudry J.P., Geretti E., Borlat F., Kungl A.J., Proudfoot A.E., and Handel T.M. Identification of the glycosaminoglycan binding site of the CC chemokine, MCP-1: Implications for structure and function in vivo. J. Biol. Chem. 279 (2004) 22294-22305
34. Laurence J.S., Blanpain C., Burgner J.W., Parmentier M., and LiWang P.J. CC chemokine MIP-1 beta can function as a monomer and depends on Phe13 for receptor binding. Biochemistry 39 (2000) 3401-3409
35. Lowman H.B., Fairbrother W.J., Slagle P.H., Kabakoff R., Liu J., Shire S., and Hebert C.A. Monomeric variants of IL-8: Effects of side chain substitutions and solution conditions upon dimer formation. Protein Sci. 6 (1997) 598-608
36. Lubkowski J., Bujacz G., Boque L., Domaille P.J., Handel T.M., and Wlodawer A. The structure of MCP-1 in two crystal forms provides a rare example of variable quaternary interactions. Nat. Struct. Biol. 4 (1997) 64-69
37. McCornack M.A., Cassidy C.K., and LiWang P.J. The binding surface and affinity of monomeric and dimeric chemokine macrophage inflammatory protein 1 beta for various glycosaminoglycan disaccharides. J. Biol. Chem. 278 (2003) 1946-1956
38. Nesmelova I.V., Sham Y., Gao J., and Mayo K.H. CXC and CC chemokines form mixed heterodimers: Association free energies from molecular dynamics simulations and experimental correlations. J. Biol. Chem. 283 (2008) 24155-24166
39. Paavola C.D., Hemmerich S., Grunberger D., Polsky I., Bloom A., Freedman R., Mulkins M., Bhakta S., McCarley D., Wiesent L., Wong B., Jarnagin K., et al. Monomeric monocyte chemoattractant protein-1 (MCP-1) binds and activates the MCP-1 receptor CCR2B. J. Biol. Chem. 273 (1998) 33157-33165
40. Paoletti S., Petkovic V., Sebastiani S., Danelon M.G., Uguccioni M., and Gerber B.O. A rich chemokine environment strongly enhances leukocyte migration and activities. Blood 105 (2005) 3405-3412
41. Proudfoot A.E., Handel T.M., Johnson Z., Lau E.K., LiWang P., Clark-Lewis I., Borlat F., Wells T.N., and Kosco-Vilbois M.H. Glycosaminoglycan binding and oligomerization are essential for the in vivo activity of certain chemokines. Proc. Natl. Acad. Sci. USA 100 (2003) 1885-1890
42. Ryu E.K., Kim T.G., Kwon T.H., Jung I.D., Ryu D., Park Y.M., Kim J., Ahn K.H., and Ban C. Crystal structure of recombinant human stromal cell-derived factor-1alpha. Proteins 67 (2007) 1193-1197
43. Shahrara S., Proudfoot A.E., Park C.C., Volin M.V., Haines G.K., Woods J.M., Aikens C.H., Handel T.M., and Pope R.M. Inhibition of monocyte chemoattractant protein-1 ameliorates rat adjuvant-induced arthritis. J. Immunol. 180 (2008) 3447-3456
44. Shaw J.P., Johnson Z., Borlat F., Zwahlen C., Kungl A., Roulin K., Harrenga A., Wells T.N., and Proudfoot A.E. The X-ray structure of RANTES: Heparin-derived disaccharides allows the rational design of chemokine inhibitors. Structure 12 (2004) 2081-2093
45. Swaminathan G.J., Holloway D.E., Colvin R.A., Campanella G.K., Papageorgiou A.C., Luster A.D., and Acharya K.R. Crystal structures of oligomeric forms of the IP-10/CXCL10 chemokine. Structure 11 (2003) 521-532
46. Tuinstra R.L., Peterson F.C., Kutlesa S., Elgin E.S., Kron M.A., and Volkman B.F. Interconversion between two unrelated protein folds in the lymphotactin native state. Proc. Natl. Acad. Sci. USA 105 (2008) 5057-5062
47. Veldkamp C.T., Peterson F.C., Pelzek A.J., and Volkman B.F. The monomer-dimer equilibrium of stromal cell-derived factor-1 (CXCL 12) is altered by pH, phosphate, sulfate, and heparin. Protein Sci. 14 (2005) 1071-1081
48. Veldkamp C.T., Seibert C., Peterson F.C., De la Cruz N.B., Haugner III J.C., Basnet H., Sakmar T.P., and Volkman B.F. Structural basis of CXCR4 sulfotyrosine recognition by the chemokine SDF-1/CXCL12. Sci. Signal 1 (2008) ra4
49. Vives R.R., Sadir R., Imberty A., Rencurosi A., and Lortat-Jacob H. A kinetics and modeling study of RANTES(9-68) binding to heparin reveals a mechanism of cooperative oligomerization. Biochemistry 41 (2002) 14779-14789
50. von Hundelshausen P., Koenen R.R., Sack M., Mause S.F., Adriaens W., Proudfoot A.E., Hackeng T.M., and Weber C. Heterophilic interactions of platelet factor 4 and RANTES promote monocyte arrest on endothelium. Blood 105 (2005) 924-930
51. Witt D.P., and Lander A.D. Differential binding of chemokines to glycosaminoglycan subpopulations. Curr. Biol. 4 (1994) 394-400
52. Yu Y., Sweeney M.D., Saad O.M., Crown S.E., Hsu A.R., Handel T.M., and Leary J.A. Chemokine-glycosaminoglycan binding: Specificity for CCR2 ligand binding to highly sulfated oligosaccharides using FTICR mass spectrometry. J. Biol. Chem. 280 (2005) 32200-32208
53. Yu Y., Sweeney M.D., Saad O.M., and Leary J.A. Potential inhibitors of chemokine function: Analysis of noncovalent complexes of CC chemokine and small polyanionic molecules by ESI FT-ICR mass spectrometry. J. Am. Soc.; Mass Spectrom. 17 (2006) 524-535